AS

Anthonyswamy Simonhercules

Active Director Director DIN 01125759
DIN 01125759 First appointment Jan 2007 Primary industry Jewelry & Fashion Accessories
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 11 historical roles
Total affiliations 13 Since Jan 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Anthonyswamy Simonhercules

Data last updated:

Anthonyswamy Simonhercules is a Director at Trydex Technologies Private Limited (since 2020) and Director at Neuro Remedies Private Limited (since 2016). The companies operate in Jewelry & Fashion Accessories, Chemicals and Materials and Pharma. Earlier, Anthonyswamy Simonhercules was a Director at Enma Pharmaceuticals Private Limited (2007–2012) and Director at Hermer Med Systems Private Limited (2008–2014) and 9 more.

DIN 01125759
Primary Designation Director
Industry Jewelry & Fashion Accessories
First Appointment 03 Jan 2007
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trydex Technologies Private Limited U33302TN2020PTC134865
Director13 Mar 20202020Active
Neuro Remedies Private Limited U51909TN2016PTC110886
Director14 Jun 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Enma Pharmaceuticals Private Limited U51397TN2004PTC053088
Director29 Sep 20072004₹2.08 Cr (FY 2025)Active
Hermer Med Systems Private Limited U85110TN2008PTC069312
Director17 Sep 20082008Active
Director03 Jan 20072007₹30.58 Cr (FY 2025)Active
Director04 Feb 20092009₹37.34 Cr (FY 2024)Active
Preventive Medicare Private Limited U85190TN2008PTC070281
Director23 Dec 20082008₹1.2 Lakh (FY 2025)Active
Neuro Lab India Private Limited U51909TN2016PTC111166
Director28 Jun 20162016Active
Director04 Nov 20112011Active
Director03 Nov 20112011Strike Off
Smat Lifeline Private Limited U85100WB2020PTC236310
Director06 Feb 20202020Strike Off
Director09 Nov 20112011Strike Off
Director20 Jan 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Anthonyswamy Simonhercules

Directorship timeline

Open interactive timeline →
Trydex Technologies Private Limited
Neuro Remedies Private Limited
Newhope Family Care Clinic Private Limited
Smat Lifeline Private Limited
Premium access

Shareholding and investment profile for Anthonyswamy Simonhercules

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anthonyswamy Simonhercules

Anthonyswamy Simonhercules currently holds 2 directorships: Trydex Technologies Private Limited (Director, since 13 Mar 2020); Neuro Remedies Private Limited (Director, since 14 Jun 2016).

Anthonyswamy Simonhercules was first appointed on 03 Jan 2007 as Director at New Hope Medical Centre Private Limited. The most recent appointment on record is 13 Mar 2020 at Trydex Technologies Private Limited.

Anthonyswamy Simonhercules held 11 earlier board appointments: Enma Pharmaceuticals Private Limited (Director, 29 Sep 2007 to 01 Dec 2012); Hermer Med Systems Private Limited (Director, 17 Sep 2008 to 26 Aug 2014); New Hope Medical Centre Private Limited (Director, 03 Jan 2007 to 15 Sep 2020); Prime Indian Hospitals Private Limited (Director, 04 Feb 2009 to 28 Jul 2014); Preventive Medicare Private Limited (Director, 23 Dec 2008 to 12 Dec 2013); and 6 more.

The current boards of Anthonyswamy Simonhercules's companies include Farook Fakhruddin (Trydex Technologies Private Limited), Palani Sasikumar (Trydex Technologies Private Limited), Anandhi Simon (Neuro Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available